Drug Type Small molecule drug |
Synonyms Mitratapide (USAN/INN), R 103757, R-103757 + [1] |
Target |
Action inhibitors |
Mechanism MTTP inhibitors(Microsomal triglyceride transfer protein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC36H41ClN8O4S |
InChIKeyHQSRVYUCBOCBLY-XOOFNSLWSA-N |
CAS Registry179602-65-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D05060 | Mitratapide | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hyperlipidemias | Phase 1 | Belgium | - | - |
| Hyperlipidemias | Phase 1 | - | - |





